Page last updated: 2024-12-08

aligeron

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Aligeron: RN given refers to parent cpd; aligeron & AS 2 are for di-HCl [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID166145
SCHEMBL ID10351966
MeSH IDM0076740

Synonyms (13)

Synonym
aligeron
1-(diphenylmethyl)-4-(2-propenyl)piperazine
1-(diphenylmethyl)-4-(2-propenyl)piperazine, dihydrochloride
piperazine, 1-(diphenylmethyl)-4-(2-propenyl)-
brn 0543456
70713-45-0
1-benzhydryl-4-prop-2-enylpiperazine
piperazine,1-(diphenylmethyl)-4-(2-propen-1-yl)-
DTXSID50220978
SCHEMBL10351966
HY-101602
CS-6748
AKOS040755377

Research Excerpts

Overview

Aligeron was found to be a non-selective PG antagonist in isolated guinea-pig stomach smooth muscle preparations.

ExcerptReferenceRelevance
"Aligeron was found to be a non-selective PG antagonist in isolated guinea-pig stomach smooth muscle preparations."( Study on the prostaglandin antagonistic activity of aligeron and piracetam.
Dimitrova, L; Dushkova, R; Nikolov, R; Pavlidu, A; Rakovska, A,
)
1.1
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.15

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.15 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.15)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]